AstraGin® (Nutrient Absorption Enhancer)

Astragalus membranaceus / Panax notoginseng
Evidence Level
Strong
2 Clinical Trials
3 Documented Benefits
4/5 Evidence Score

AstraGin® (NuLiv Science) is the most widely used patented nutrient absorption enhancer in the supplement industry — a synergistic extract of Astragalus membranaceus and Panax notoginseng saponins found in hundreds of supplements globally. Over 20 studies (in vitro, preclinical, and human) demonstrate AstraGin® increases the absorption of amino acids, peptides, fatty acids, vitamins, creatine, citrulline, and curcumin by upregulating intestinal transporter protein expression. A landmark 2026 human RCT published in Nutrients confirmed AstraGin® enhances whey protein amino acid absorption and improves muscle function across all age groups.

Studied Dose 25–50 mg/day as absorption enhancer (co-ingredient); 100 mg/day for gut health applications; included in hundreds of supplement formulas as a supporting absorption-enhancing ingredient
Active Compound Astragalus membranaceus root extract + Panax notoginseng root extract in patented ratio — AstraGin® by NuLiv Science; standardized for astragalosides and ginsenosides; standard dose 25–50 mg/day as a co-ingredient

Amino acid and protein absorption enhancement

A 2026 double-blind RCT in 30 healthy adults published in Nutrients confirmed AstraGin® significantly improved the absorption of key amino acids from whey protein — with improved muscle strength and mass after 4 weeks of resistance training. AstraGin® increases the expression of PEPT1 (peptide transporter) and amino acid transporter proteins in intestinal epithelium, enabling greater amino acid uptake per gram of dietary protein consumed.

Multi-nutrient bioavailability improvement

Over 20 studies confirm AstraGin® increases the absorption of a broad range of nutrients including L-citrulline, creatine, folate, glucosamine, curcumin, vitamins B1/B9/B12/C/D, and omega-3 fatty acids. This broad-spectrum absorption enhancement makes AstraGin® one of the most versatile co-ingredients in supplement formulation — improving the efficacy of virtually any formula it is included in.

Gut health and microbiome support

A human clinical trial in participants with gut health concerns demonstrated AstraGin® (100 mg/day, 3 months) significantly improved intestinal barrier integrity, increased beneficial bacteria populations (420% increase in Faecalibacterium prausnitzii, 180% increase in Bifidobacterium adolescentis), and reduced harmful bacteria — positioning AstraGin® as both an absorption enhancer and a gut health ingredient.

1

Intestinal transporter upregulation and tight junction support

AstraGin® astragaloside IV and ginsenoside Rb1 upregulate the expression of intestinal nutrient transporter proteins (SGLT1, PEPT1, CAT1) through NF-κB modulation and mTOR-mediated protein synthesis — increasing the transport capacity of intestinal epithelial cells for amino acids, glucose, and other nutrients. Simultaneously, AstraGin® strengthens tight junction proteins (ZO-1, occludin) reducing intestinal permeability and improving the selective barrier function that underlies both nutrient absorption efficiency and immune defense.

1
AstraGin® Whey Protein Absorption and Muscle Function — Double-Blind RCT
PubMed

Randomized, double-blind, placebo-controlled crossover trial of AstraGin® effects on amino acid absorption from whey protein and muscle function. Published in Nutrients, 2026.

30 healthy adults across three age groups. Two-phase study: acute absorption + 4-week resistance training.

AstraGin® significantly improved amino acid absorption kinetics from whey protein in the acute phase. After 4 weeks of training, AstraGin® group showed improved muscle strength and mass vs. placebo. Gut permeability biomarkers improved. Supports AstraGin® as absorption enhancer improving protein supplementation efficacy.

2
AstraGin® Gut Health — Human Clinical Trial
PubMed

Human clinical trial of AstraGin® (100 mg/day) effects on gut health markers, microbiome composition, and intestinal barrier integrity.

Adults with gut health concerns. 3-month supplementation.

AstraGin® produced 420% increase in Faecalibacterium prausnitzii, 180% increase in Bifidobacterium adolescentis, significantly improved intestinal barrier integrity, and reduced pathogenic bacteria populations. Published in Journal of Biochemistry and Biotechnology.

Common Potential side effects

Excellent safety profile at 25–50 mg supplemental dose
Generally recognized as safe across 20+ studies
No adverse effects reported at standard co-ingredient doses

Important Drug interactions

Drug absorption — AstraGin® may increase absorption of medications taken simultaneously; space medications separately if concerned
No established drug interactions at standard 25–50 mg supplemental doses